Skip to main content
See every side of every news story
Published loading...Updated

The View of Raiffeisen Chief Economists: Pharma Wake-up Call

Summary by Moneycab
Customs duties are not an unproblematic instrument for driving the pharmaceutical industry to a halt, but they impose a burden on the pharmaceutical industry, but they also increase drug prices and thus increase the costs for end-users.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Customs duties are not an unproblematic instrument for driving the pharmaceutical industry to a halt, but they impose a burden on the pharmaceutical industry, but they also increase drug prices and thus increase the costs for end-users.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Moneycab broke the news in on Thursday, October 2, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal